| Primary |
| Mycobacterium Avium Complex Infection |
29.4% |
| Mycobacterial Infection |
11.1% |
| Atypical Mycobacterial Infection |
10.0% |
| Helicobacter Infection |
8.3% |
| Tuberculosis |
7.8% |
| Crohn's Disease |
7.2% |
| Meningitis Tuberculous |
5.0% |
| Helicobacter Gastritis |
3.3% |
| Hiv Infection |
2.8% |
| Pulmonary Tuberculosis |
2.2% |
| Atypical Mycobacterial Pneumonia |
1.7% |
| Hyperuricaemia |
1.7% |
| Lymph Node Tuberculosis |
1.7% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
| Cytomegalovirus Retinitis |
1.1% |
| Hepatitis B |
1.1% |
| Hepatitis C |
1.1% |
| Ill-defined Disorder |
1.1% |
| Myocardial Ischaemia |
1.1% |
| Pathogen Resistance |
1.1% |
|
| White Blood Cell Count Decreased |
15.8% |
| Interstitial Lung Disease |
9.2% |
| Pyrexia |
7.9% |
| Vomiting |
7.9% |
| Headache |
5.3% |
| Liver Disorder |
5.3% |
| Skin Discolouration |
5.3% |
| Death |
3.9% |
| Loss Of Consciousness |
3.9% |
| Myocardial Infarction |
3.9% |
| Pigmentation Disorder |
3.9% |
| Rhabdomyolysis |
3.9% |
| Thalamus Haemorrhage |
3.9% |
| Transaminases Increased |
3.9% |
| Bone Marrow Failure |
2.6% |
| Chromaturia |
2.6% |
| Glycosylated Haemoglobin Increased |
2.6% |
| Mycobacterium Avium Complex Infection |
2.6% |
| Platelet Count Decreased |
2.6% |
| Psychotic Disorder |
2.6% |
|
| Secondary |
| Hiv Infection |
24.1% |
| Mycobacterium Avium Complex Infection |
14.0% |
| Tuberculosis |
10.1% |
| Atypical Mycobacterial Infection |
9.9% |
| Acquired Immunodeficiency Syndrome |
5.3% |
| Product Used For Unknown Indication |
5.1% |
| Lymph Node Tuberculosis |
4.1% |
| Pericarditis Tuberculous |
3.9% |
| Prophylaxis |
2.9% |
| Crohn's Disease |
2.4% |
| Mycobacterial Infection |
2.4% |
| Atrial Fibrillation |
2.2% |
| Acne |
1.9% |
| Cardiac Failure |
1.9% |
| Lower Respiratory Tract Infection Bacterial |
1.9% |
| Skin Papilloma |
1.9% |
| Atypical Mycobacterium Test Positive |
1.7% |
| Cytomegalovirus Infection |
1.7% |
| Pneumocystis Jiroveci Pneumonia |
1.4% |
| Cytomegalovirus Chorioretinitis |
1.2% |
|
| Sputum Discoloured |
13.3% |
| Pancytopenia |
8.3% |
| Cytomegalovirus Chorioretinitis |
6.7% |
| Mycobacterium Avium Complex Infection |
6.7% |
| White Blood Cell Count Decreased |
6.7% |
| Joint Swelling |
5.0% |
| Maternal Exposure During Pregnancy |
5.0% |
| Neutrophil Count Decreased |
5.0% |
| Pyrexia |
5.0% |
| Visual Impairment |
5.0% |
| Anxiety |
3.3% |
| Drug Eruption |
3.3% |
| Drug Interaction |
3.3% |
| Drug Resistance |
3.3% |
| Dyspnoea |
3.3% |
| Immune Reconstitution Inflammatory Syndrome |
3.3% |
| Immune Reconstitution Syndrome |
3.3% |
| Pneumonia |
3.3% |
| Renal Disorder |
3.3% |
| Thirst |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
35.3% |
| Hiv Infection |
18.5% |
| Drug Use For Unknown Indication |
8.5% |
| Mycobacterium Avium Complex Infection |
6.5% |
| Kaposi's Sarcoma Aids Related |
6.2% |
| Tuberculosis |
3.7% |
| Atypical Mycobacterial Infection |
3.0% |
| Rheumatoid Arthritis |
2.5% |
| Acquired Immunodeficiency Syndrome |
2.1% |
| Infection |
2.1% |
| Mycobacterial Infection |
2.1% |
| Lyme Disease |
1.8% |
| Pulmonary Tuberculosis |
1.2% |
| Brain Abscess |
0.9% |
| Cytomegalovirus Infection |
0.9% |
| Depression |
0.9% |
| Fabry's Disease |
0.9% |
| Hypothyroidism |
0.9% |
| Oral Candidiasis |
0.9% |
| Pain |
0.9% |
|
| Off Label Use |
7.7% |
| Progressive Multifocal Leukoencephalopathy |
7.7% |
| Vomiting |
7.7% |
| Weight Decreased |
7.7% |
| Wrist Deformity |
7.7% |
| Fall |
5.1% |
| Immune Reconstitution Syndrome |
5.1% |
| Irritability |
5.1% |
| Kaposi's Sarcoma |
5.1% |
| Mycobacterial Infection |
5.1% |
| Optic Neuritis |
5.1% |
| Renal Disorder |
5.1% |
| Septic Shock |
5.1% |
| Stevens-johnson Syndrome |
5.1% |
| Abdominal Abscess |
2.6% |
| Alanine Aminotransferase Increased |
2.6% |
| Blood Pressure Decreased |
2.6% |
| Cd4 Lymphocytes Decreased |
2.6% |
| Cytomegalovirus Chorioretinitis |
2.6% |
| Dizziness |
2.6% |
|
| Interacting |
| Hiv Infection |
28.6% |
| Tuberculosis |
22.9% |
| Mycobacterium Test |
17.1% |
| Neck Pain |
7.1% |
| Antifungal Prophylaxis |
5.7% |
| Depression |
5.7% |
| Insomnia |
5.7% |
| Vitamin Supplementation |
5.7% |
| Deep Vein Thrombosis |
1.4% |
|
| Neutrophil Count Decreased |
27.3% |
| Hallucination, Auditory |
18.2% |
| Irritability |
18.2% |
| Melaena |
18.2% |
| Abdominal Pain |
9.1% |
| Drug Interaction |
9.1% |
|
